Abstract. Initial assembly of extracellular matrix occurs within a zone immediately adjacent to the chondrocyte cell surface termed the cell-associated or periceUular matrix. Assembly within the periceUular matrix compartment requires specific cell-matrix interactions to occur, that are mediated via membrane receptors. The focus of this study is to elucidate the mechanisms of assembly and retention of the cartilage pericellular matrix proteoglycan aggregates important for matrix organization. Assembly of newly synthesized chondrocyte pericellular matrices was inhibited by the addition to hyaluronan hexasaccharides, competitive inhibitors of the binding of hyaluronan to its cell surface receptor. Fully assembled chondrocyte pericellular matrices were displaced using hyaluronan hexasaccharides as well.
When exogenous hyaluronan was added to matrixfree chondrocytes in combination with aggrecan, a pericellular matrix equivalent in size to an endogenous matrix formed within 30 min of incubation. Addition of hyaluronan and aggrecan to glutaraldehyde-fixed chondrocytes resulted in matrix assembly comparable to live chondrocytes. These matrices could be inhibited from assembling by the addition of excess hyaluronan hexasaccharides or displaced once assembled by subsequent incubation with hyaluronan hexasaccharides. The results indicate that the aggrecanrich chondrocyte pericellular matrix is not only on a scaffolding of hyaluronan, but actually anchored to the cell surface via the interaction between hyaluronan and hyaluronan receptors.
T am initial assembly of the chondrocyte extracellular matrix most likely occurs near the cell surface within a zone termed the cell-associated or pericellular matrix. How this assembly is regulated by the chondrocytes and how the matrix itself is anchored to the cell surface is largely unknown. Hyaluronan, a high molecular weight matrix polysaccharide, has a central role in the organization of the extracellular matrix of cartilage as the backbone of the cartilage proteoglycan aggregate (Hascall and Heinegard, 1974; Christner et al., 1977) . In the pericellular matrix of chondrocytes where it is an essential matrix component, hyaiuronan may not only serve a structural role, but other functions as well.
Chondrocytes in culture exhibit large pericellular matrices extending from the plasma membrane which can be readily visualized by a particle exclusion assay (Clarris and Fraser, 1968; Goldberg and Toole, 1984; Knudson and Toole, 1985) . Small particles when added to low density cultures settle onto the culture dish, and are excluded from a distinct zone surrounding the chondrocytes. This zone or "coat" defines the chondrocyte pericellular matrix. A major component of this matrix is the large, chondroitin sulfate-rich aggregating proteoglycan, termed '~ggrecan" (Doege et al., 1991) . Treatment of chondrocytes with a small amount of 1. Abbreviations used in this paper: CMF-PBS, Calcium-and magnesiumfree PBS; HAs, hyaluronan hexasaecharides; polyhema, poly-2-hydroxyethylmethacrylate. Kimura (Henry Ford Hospital, Detroit, MI) . The two chondrocyte types were cultured in DME (4.5 g/l glucose) containing 10% FBS (Hyclone, Logan, UT), 1% penicillin/streptomycin solution, 50 #g/ml ascorbic acid and 2 mM glntamine, at 37~ in 5% CO2/95% air. Chondrocytes were also grown in suspension cultures over poly-2-hydroxyethylmcthacrylate coating (polyhema; Aldrich, Milwaukee, WI) in complete medium. To coat the surface, 35-mm tissue culture dishes containing 2 ml of 0.06% polyhcma in ethanol were incubated to dryness at 37~
Particle Exclusion Assay
The particle exclusion assay followed a protocol described previously for cells in monolayer culture (Knudson and Toole, 1985) . The culture medium was removed and replaced with 750 #l of a suspension of formaldehydefixed RBCs (108/ml) in PBS/0.1% BSA. The particles settled in 10 rain, and the cells were then observed by phase-contrast microscopy. To visualize the pericellular matrix assembled by chondrocytes in suspension culture, cells were transferred to 6-well flat-bottom tissue culture plates and spun at 500 g for 15 rain in an Omnifuge microtiter plate holder before the addition of particles.
Morphometric Analysis of Matrix to Cell Area
A matrix/cell ratio, defined as the ratio of the area delimited by the perimeter of the pericellular matrix to the area delimited by the plasma membrane, was determined by tracing the matrix and cell perimeters on a digitizing tablet using Sigma Scan software (Jandel Scientific, Corte Madera, CA; Knudson and Toole, 1985) . The matrix/cell ratio was ,x,l.0 if no detectable periccllular matrix was present. The values given represent the mean matrix/cell ratio and the 95 % confidence range from the mean. Experimental groups were compared with regard to control by a t test.
Enzymatic Removal of PericeUular Matrix
For studies on assembly of newly synthesized pericellular matrix, the endogenous pericellular matrices were removed by adding 20 ~1 of a 100 U/ml solution of Streptomyces hyaluronidase (type IX) directly to 24-h chondrocyte cultures, containing complete culture medium with 10% FBS, and incubating the cells for 1 h at 37~ followed by HBSS washes. After this treatment, the ceils were "matrix-free" by the particle exclusion assay. Following Streptomyces hyaluronidase treatment, some cells were fixed in 1% glutaraldehyde (EMS, Fort Washington, PA) in PBS, for 5 rain, and then rinsed with PBS/I% BSA.
Matrix Assembly and Displacement Studies
The influence of HA6 or high molecular weight hyaluronan on matrix assembly was studied. HAs can compete for the binding of hyaluronan to its receptor but cannot support proteoglycan aggregate formation. Chondrocytes were made matrix-free with Streptomyces hyaluronidase. 1Ceassembly of the endogenous pericellular matrix was monitored in complete medium or medium containing hyaluronan (250/~g/mi), or HA6 (25-125 #g/ml).
The ability of exogenous hyaluronan and HAS to displace the endogenous matrix made by chondrocytes in suspension culture over polyhema, or chondrocytes grown as attached ceils in monolayer, was also determined. Cells grown under these culture conditions for 2 to 48 h were incubated for 2 to 3 h more in the presence or absence of hyaluronan or HA6 before the particle exclusion assay.
Preparation and Addition of

Exogenous Macromolecules
To test the ability of chondrocytes to assemble a pericellular matrix with exogenous macromolecules, hyaluronan and aggrecan were added to matrix-free live or glutaraldchydc-fixed cells. Initially, aggrecan derived from several sources was tested; monomer preparations from the Swarm rat chondrosarcoma were gifts from Drs. J. Kimura and 1". Giant (Henry Ford Hospital, Detroit, MI and Rush-Presby~rian-St. Luke's Medical Center, Chicago, IL, respectively), and, proteoglycan monomers derived from adult bovine articular or nasal cartilages were gifts from Dr. E. Thonar (RushPresbyterian-St. Luke's Medical Center). Subsequently, proteoglycan was extracted from rat chondrosarcoma tumor homogenate according to Faltz et al. (1979) and isolated by dissociative cesium chloride equilibrium centrifugation in 4.0 M guauldine HC1 with protease inhibitors at a starting density of 1.5 g/ml (Hascall vtal., 1976) for 50 h at 100,000 g at 10~
The bottom 1/4th of the gradient, density >1.6 g/ml, was collected and recentrifuged. The bottom 1/4th of the second gradient was collected (DID1 fractions), dialyzed, and lyophilized. The D1DI fractions were incubated with Streptomyces hyaluronidase to degrade small concentrations of hyaluronan found within these preparations. The proteoglycans were recovered by another dissociative equilibrium centrifugation.
HA6 were prepared by digestion of hyaluronan (grade I) with testicular hyaluronidase (type I-S) with 172 USP/NFU hyaluronidase/mg hyaluronan (Knudson et al., 1984; Kimura et al., 1979; Hascall and Heinegard, 1974) . The hyaluronan oligosaccharides were separated on a 2.5 x 118 cm column of Bit-gel P30 in 0.5 M pyridinium acetate (Solursh et al., 1980; Knudson and Knudson, 1991) .
In parallel experiments, the glycosaminoglycan chondroitin sulfate was added to chondrocytes cultures. Chondroitin sulfate (grade III) was pretreated with Streptomyces hyaluronidase, boiled, precipitated in 1.3% potassium acetate in 95% ethanol. Chondroitin sulfate hexasaccharides were prepared by testicular hyaluronidase digestion, purified by Bit-gel P-30 chromatography as above.
Additions to matrix-free chondrocytes were DME containing either: (a) no additional components; (b) 2.0 mg/ml proteoglycan monomer; (c) 12 ~g/ml hyaluronan; (d) 2.0 mg/ml proteoglycan monomer plus 12 /~g/ml hyaluronan (determined empirically as optimal, data not shown); or (e) 2.0 mg/ml proteoglycan monomer, 12 t~g/ml hyaluronan, and 100/~g/ml HA6.
The hyaluronic acid binding region of D1D1 proteoglycan was separated from the chondroitin sulfate-rich fragment by dissociative cesium chloride gradient centrifugation as above, after clostripain digestion (Caputo et al., 1980) . Reduction/alkylation of proteoglycan was by treatment with 20 mM DTT followed by addition of iodoacetamide (Hardingham et al., 1976) . The products of chondroitinase ABC digestion (Hascall and Heinegard, 1974) , were separated by Sephacryl S-300 chromatography in PBS. The proteoglycan core protein, containing chondroitin-4-sulfate stubs, was detected using 9-A-2/E9 antibody (ICN Biomedicals, Inc., Irvine, CA). Residual chondroitinase activity was detected in later eluting fractions by 3H-hyaluronan degradation assays . Modified proteoglycan was lyophilized, dissolved in DME at 10 ng/ml, and added to matrix-free chondrocytes at the same concentration as the native proteoglycan.
The ability of aggrecan to associate with chondrocytes in monolayer culture was tested by adding 3H-aggrecan to matrix-free chondrocytes or to chondrocytes with an endogenous pericellular matrix. The 3H-aggrecan (Byers et al., 1987) was added at 1 mg/ml (62,000 cpm/mg) serum-free DME per 105 cells for 2 h at 37~ Cells were then rinsed three times with serum-free DME; the radioactivity was released from the culture dishes with 1% SDS.
Proteoglycan Biosynthesis in the Presence of Hyaluronan Hexasaccharides
Matrix-free chondrocytes were incubated with 25 #Ci/ml of [35S]sulfuric acid (43 Ci/mg; ICN Biomedicals) in the presence or absence of 250 t~g/ml HA6. The media fractions were collected at 24 and 48 h and analyzed by descending chromatography (Knudson et al., 1984) . Chondroitinase ABCsensitive radioactivity at the origin of the strip represented incorporation into chondroitin sulfate proteoglycan. Samples were also run on a Sepharose CL-2B column in 0.5 M sodium acetate, 0.1% Triton X-100, pH 6.8, with and without pre-aggregation with hyaluronan for 24 h . The percentage of macromolecular [35S]sulfate-labeled material eluting at the Vo of the column represents the capacity of the radiolabeled proteoglycan to form stable aggregates with hyaluronan.
Results
Inhibition of Matrix Assembly
Our model system for matrix assembly uses chondrocytes in monolayer (Fig. 1, a and b) or suspension culture. The matrix of these chondrocytes was removed with Streptomyces hyaluronidase, and then reassembly of newly synthesized pericellular matrices was followed from 2 h up to 5 d. This matrix assembly was monitored in the presence of HA6 to test the hypothesis that receptor-bound hyaluronan, that exhibits competition via a hexasaccharide, functions to anchor the chondrocyte pericellular matrix. Chondrocytes stripped of their pericellular matrix with hyaluronidase reassembled a small pericellular matrix by 3 h and a typical matrix (Fig.  1, c and d ) by 24 h. Fig. 1 , e and f, shows that matrix assembly on both chick embryo chondrocytes and rat chondrocytes was inhibited by the presence of 0.25 mg/ml HA6 in the medium. In the extended presence of 0.25 mg/ml HAs, no matrix was detected after 5 d of culture (data not shown). In these studies, the HA6 were added at time zero, and there were no further additions to the cultures.
Chondrocytes that had no matrix after a 24-h incubation in the presence of HA6 (as in Fig. 1 , e and f), were rinsed twice in HBSS and then incubated in fresh medium. As shown in Table I , after 4 h a small pericellular matrix was observed on these chondrocytes and by 24 h following the wash out of HA6, pericellular matrix assembly was similar in size to chondrocytes in culture for 24 h.
There was a dose-dependent inhibition of matrix assembly by HA~ as shown in Table II . Addition of hyaluronan did not inhibit matrix assembly. The time course for matrix assembly on chondrocytes in monolayer culture following Streptomyces hyaiuronidase treatment in the presence or absence of exogenous hyaluronan was nearly identical (Table  III) . In the presence of chondroitin sulfate or its hexasaccharides pericellular matrix assembly was similar to controls for chick chondrocytes, although rat chondrocyte matrix size was decreased somewhat (P < 0.02). The concentration of chondroitin sulfate in these cultures has a viscosity nearly equal to that of the hyaluronan solution (Forrester and Lackie, 1981) .
Displacement of FuUy Assembled Pericellular Matrix
When chondrocytes in monolayer culture for 20 h (Fig. 2 , a and c) were subsequently incubated for an additional 2 h in medium containing HA6, the entire pericellular matrix was displaced (Fig. 2 , b and d; see also Table IV) . Although we had shown previously that hyaluronan could displace radiolabeled hyaluronan and chondroitin sulfate from the chondrocyte cell surface , addition of hyaluronan did not displace the fully assembled endogenous pericellular matrix (Table IV) . Also the addition of chondroitin sulfate, chondroitin sulfate hexasaccharides, or proteoglycan monomer did not displace the fully assembled endogenous pericellular matrix (Table IV) . Exogenous aggrecan monomer may also be incorporated into a hyaluronan-anchored periceUular matrix since the matrix size was increased in the presence of aggrecan (P < 0.001). Chondroitin sulfate hexasaccharides did not displace the matrix, indicative of the specificity of the hyaluronan receptor.
Matrix Assembly and Displacement on Chondrocytes Grown in Suspension Culture
Chondrocytes were grown in suspension over polyhemacoated plastic for 48 h, then centrifuged at 500 g for 15 min onto plastic for immediate analysis by the particle exclusion assay. 90% of the cells adhered were viable by trypan blue exclusion, and exhibited a periceUular matrix (Fig. 3 , a and c). If ceils from 48 h suspension cultures were incubated for an additional 3 h in the presence of HA6 and then visualized, the endogenous matrix was displaced (Fig. 3, b and d) . Figure 1 . Chondrocyte pericellular matrix assembly; inhibition by hyaluronan hexasaccharides. Chondrocytes grown in monolayer were well-spread 24 h following plating (a and b). These chondrocytes, stripped of matrix with hyaluronidase, reassembled a pericellular matrix in complete medium after 24 h as observed with the particle exclusion method (c and d). However, if chondroeytes were stripped of matrix and then incubated with 0.25 mg/ml HA~ no matrix was observed after 24 h (e and f). a, c, and e show embryonic chick chondrocytes; b, d, and f show rat chondrocytes. Bar, 50/zm.
Matrix Assembly with Exogenous Hyaluronan and Aggrecan
To determine which molecules are required for pericellular matrix assembly, exogenous aggrecan, hyaluronan, and HA~ were added in combinations to matrix-free rat and chick chondrocytes. No matrix assembled for up to 2 h when hyaluronan alone (Fig. 4, c and d ) was added. Addition of 3H-hyaluronan to these cells resulted in specific, saturable binding (chick chondrocytes Kd ~ 6 X 10 -9 M; Knudson and Toole, 1987 ; rat chondrocytes Ko = 10 -1~ M; McCarthy and , but hyaluronan alone was not sufficient for matrix assembly. No matrix assembled for up to 2 h when aggrecan alone (Fig. 4 , e and f ) was added. A large pericellular matrix assembled within 30 man when both hyaluronan and aggrecan were added to matrix-free chick or rat chondrocytes (Fig. 4, g and h) . No endogenous matrix was detected in control cultures at this time point, or by 2 h (Fig.  4, a and b) . The presence of HA6 prevented the assembly of hyaluronan and aggrecan into a pericellular matrix; no matrix was observed after 2 h (Fig. 4, i and j ) , 4 or 48 h (data not shown).
Proteoglycan monomer incorporation into a hyaluronananchored pericellular matrix was further studied by adding 3H-aggrecan to monolayer cultures of chondrocytes either immediately following matrix removal by Streptomyces hyaluronidase, or after 24 h of matrix regrowth. Aggrecan did not bind to the monolayers of matrix-free chondrocytes, but exogenous aggrecan did become associated with the monolayers of chondrocytes with fully assembled pericellular matrices (Table V) .
Specificity of HA6 D!splacement of Matrix
Exogenous pericellular matrices were established on matrixfree chondrocytes using exogenous link-stabilized aggrecan/hyaluronan aggregates. The cells assembled a pericellular matrix with the exogenous components within 90 min Matrix-free chondroeytes were grown in monolayer culture for 2 or 20 h. At these time points, the medium was removed and replaced with medium alone or medium containing hyaluronan, HA6, chondroitin sulfate, chondroitin sulfate (ChSO4), hexasaecharides, or rat chondrosarcoma proteoglycan monomer, and all cultures were incubated for an additional 2 h.
(matrix/cell ratio = 2.5 + 0.2). When chondrocytes with a reassembled link-stabilized periceUular matrix (90 min) were subsequently incubated with fresh media containing HA~ for 2 h, the periceUular matrix was displaced (matrix/cell ratio = 1.12 + 0.15). Since link protein-stabilized aggrecan/hyaluronan aggregates cannot be disrupted by hyaluronan or hyaluronan oligosaccharides (Hascall and Heinegard, 1974) , these results support that matrix displacement occurred via competition of HA6 for hyaluronan/ hyaluronan receptor binding.
Domain Structure of Aggrecan Required for PericeUular Matrix Assembly
Aggrecan from bovine nasal and bovine articular cartilage were compared and found to support matrix assembly with hyaluronan on rat chondrocytes as effectively as rat ehondrosarcoma aggrecan (matrix/cell ratios = 3.06 + 0.30; 3.40 + 0.21, respectively). Modified rat chondrosarcoma aggrecan was added to matrix-free chondrocytes to determine the domain structure of aggrecan required for matrix assembly; the following results are shown in Table VI . If hyaluronan and reduced/alkylated aggrecan were added, no matrix assembled; this suggests that matrix assembly is mediated via the interaction of the hyaluronic acid binding region of aggrecan with hyaluronan. However, if either the hyaluronic acid binding region or the chondroitin sulfate-rich region, obtained by clostripain digestion of aggrecan followed by cesium chloride gradient centrifugation, were added in the presence of hyaluronan, no matrix assembled. If hyaluronan and chondroitinase ABC pre-treated aggrecan monomer (which stills aggregates with hyaluronan, but has only stubs of chondroitin sulfate) were added, no matrix assembled. dase-treated chick (a, c, e, g, and i) and rat (b, d,f, h, and J3 chondrocytes were incubated with either: medium alone for 2 h (a and b); medium containing hyaluronan for 2 h (c and d); medium containing aggrecan for 2 h (e and jr); medium containing hyaluronan plus aggrecan for 30 min (g and h); or medium containing hyaluronan plus aggrecan plus HA6 for 2 h (i and j). Only cells incubated in the presence of both hyaluronan and aggrecan exhibited significant pericellular matrices (g and h) and the inclusion of HA~ inhibited matrix formation with these macromolecules (i and j). Bar, 50 #m. Monolayer chondrocyte cultures were pre-treated with Streptomyces hyaluronidase, and incubated in serum-free medium containing ~H-aggrecan (O h), or allowed to regrow a matrix for 24 h in complete medium, and then incubated with 3H-aggrecan (24 h).
PericeUular Matrix Assembly on Glutaraldehyde-fixed Chondrocytes
To exclude the possibility that exogenous matrix components stimulated endogenous matrix synthesis and assembly, studies were performed on fixed, non-living cells. It is known from previous studies that hyaluronan receptors are stable to mild fixation with glutaraldehyde and still bind 3H-hyaluronan with specificity and affinity comparable to live cells (Nemec et al., 1987) . After incubation of matrixfree glutaraldehyde-fixed chondrocytes in serum-free medium containing hyaluronan and aggrecan, a pericellular matrix assembled (Fig. 5, a and b) . Pericellular matrices on fixed chondrocytes did not form without the addition of the exogenous hyaluronan and aggrecan. Addition of equivalent concentrations of hyaluronan without aggrecan or, aggrecan without hyaluronan to the fixed chondrocytes did not result in pericellular matrix assembly. Addition of excess HA6 inhibited matrix assembly in the presence of exogenous hyaluronan and aggrecan. The persistence or stability of these exogenous pericellular matrices on fixed chondrocytes was determined. The cells were rinsed to remove the hyaluronan and aggrecan still in solution and not bound to the cells, and fresh medium with or without HA6 added. After 24 h, these fixed chondrocytes in medium alone, retained the matrix (Fig. 5, c and d) . However, if the fresh medium contained HA6, the matrix formed by exogenous hyaluronan and aggrecan on fixed chondrocytes was displaced (Fig. 5, e and f) . Also, the matrix formed by exogenous hyaluronan and aggrecan on fixed chondrocytes was removed by treatment with Streptomyces hyaluronidase (matrix/cell ratio = 1.03 + 0.02).
To insure the absence of the hyaluronan receptor, chondrocytes were treated with 0.25% trypsin for 60 min, rinsed, and fixed with glutaraldehyde. No binding of 3H-hyaluronan to ceils is detected following trypsin treatment Nemec et al., 1987) . After incubation of trypsin-pretreated, fixed chondrocytes in suspension with optimal concentrations of hyaluronan and aggrecan, no pericellular matrix assembled (matrix/cell ratio = i.i0 + 0.04), whereas matrix assembly did occur on fixed, nontrypsin treated chondrocytes (Fig. 5, a and b) . , and f) chondrocytes, which were trypanblue inclusive, were incubated in DME containing hyaluronan and aggrecan; matrix assembly was observed at 24 h (a and b). This medium was removed and replaced with new DME for 24 h or DME containing HA~ for 3 h. Cells in DME alone, representing non-specific shedding into the culture medium, retained the matrix (c and at). Incubation of cells in DME containing HA6 resulted in the displacement of the pericellular matrix from the fixed chondrocytes (e and f). Bar, 50/~m. 
Aggregation Competence of Newly Synthesized Proteoglycans
To test whether aggrecan synthesized in the presence of HAs has the same capacity to aggregate with hyaluronan, 35S-proteoglycans obtained from the medium of chondrocytes cultured in the presence or absence of HAs were compared. The capacity of the 3sS-proteoglycan to form stable aggregates with hyaluronan was determined as the percentage of proteoglycan eluting at the Vo of a Sepharose CL-2B column after aggregation with 6 % exogenous hyaluronan for 24 h. In the presence of HAs the percentage of aggregating proteoglycans at 24 h was slightly increased for both cell types; however, equivalent percentage of aggregating proteoglycans were found in the medium at 48 h (Table VII) .
Discussion
Although many matrix macromolecules within cartilage are capable of cell-free self-assembly, the hypothesis of this study is that initial assembly occurs within a zone immediately adjacent to the chondrocyte cell surface termed the cell-associated or pericellular matrix. The three components of the matrix aggregate in cartilage-hyaluronan, aggrecan and link protein-are synthesized by the chondrocytes. Of these three, only aggrecan and link protein pass through the RER and Golgi compartments, where cytoplasmic interactions could occur (Hardingharn et al., 1992) . The current model for hyaluronan biosynthesis is of a plasma membrane enzyme complex, by which newly elongating hyaluronan is extruded to the extracellular matrix (Prehm, 1989; Ng and Schwartz, 1989) . Thus aggrecan and link protein can only interact with hyaluronan extracellularly. Previous studies indicated specific interaction between the hyaluronan acid binding region of aggrecan and hyaluronan at the chondrocyte cell surface (Sommarin and Heinegard, 1983) , but aggrecan receptors have not been detected. Also, newly secreted aggrecan is converted, in the extracellular matrix, to a form with a higher finding affinity for hyaluronan (Sandy and Plaas, 1989; . The control or catalysis of cartilage matrix assembly may therefore require specific cell-matrix interactions, which are in turn, mediated via membrane binding proteins or receptors. The interactions of matrix macromolecules with cell surface receptors would allow macromolecules to be clustered in proportions and concentrations which assure optimal assembly in the pericellular compartment. The pericellular matrix, once assembled, may then serve as a nucleating template for territorial or interterritorial matrix organization. Extensive pericellular matrices, of varying thicknesses, have been visualized surrounding a wide variety of eukaryotic cells in culture (Laurent and Fraser, 1992) . The principal feature known concerning the structural composition of these pericellular matrices is that they are dependent on hyaluronan. In previous studies, however, we observed that cells of embryonic limb mesenchyme could turn on, or off, the expression of pericellular matrices without change in the levels of their cell surface hyaluronan, suggesting that other components are required for matrix formation (Knudson and Toole, 1985) . The removal of the chondrocyte pericellular matrix by treatment with a dilute solution of Streptomyces hyaluronidase, led to the hypothesis that a network of hyaluronan is the scaffold for the chondrocyte pericellular matrix, to which other matrix macromolecules are bound Toole, 1985, 1987) . The in vivo presence or function of extensive pericellular matrices which surround many cell types in culture is not well established. Clearly, the expression of pericellular matrices around chondrocytes correlates well with their primary cellular function; to generate and organize an extraceUular matrix capable of withstanding load forces. The interactions of chondrocytes with the extracellular matrix may provide a mechanism for the cells to respond to the composition and/or mechanical properties of this surrounding matrix. The degree of extracellular matrix surrounding chondrocytes in vivo also seems to correlate well with the expression of pericellular matrices in vitro, suggesting that these structures do in fact exist in vivo (Knudson and Toole, 1985) .
To determine that these cell-associated matrices visualized by the particle exclusion assay were not an artifact of monolayer culture, we developed techniques to analyze chondrocytes grown in suspension culture. Via a modified cytospin technique, cells in suspension were centrifuged ("splatted'3 onto a plastic well assay surface. The cells were found to exhibit pericellular matrices similar to those observed on chondrocytes grown on monolayer culture. Thus, cells in suspension also elaborate a pericellular matrix which can be visualized in our two-dimensional assay by the rapid splatting of cells before visualization. With this method it was now possible to determine whether chondrocytes elaborate such a matrix in vivo. In a preliminary study (Knudson, C. B. 1991. J. Cell Biol. 115:297) , chondrocytes were isolated from the 12-d embryonic chick tibiae by a 10-min treatment of the cartilage with purified collagenase P (Boehringer Mannheim Biochemicals, Indianapolis, IN), in medium containing 20% FBS. The freshly isolated single cells were diluted, splatted onto the six-well plastic culture surface and visualized by the particle exclusion assay. The newly isolated chondrocytes exhibited prominent pericellular matrices (matrix/cell ratio = 3.21 + 0.20) similar in size to the cultured chondrocytes. This matrix was displaced by subsequent 3-h incubation in medium with HAS.
The first conclusion of this study is that the ability to assemble a pericellular matrix requires the expression of cell surface hyaluronan binding sites or "receptors" and the interaction of hyaluronan with these receptors. This conclusion was drawn because the pericellular matrices could be prevented from assembling or, displaced from the cells once assembled, via the addition of an excess of HAs, competitive inhibitors of the binding of hyaluronan to its receptor. These results suggest that the pericellular matrix is not only on a scaffolding of a hyaluronan network but actually anchored to the chondrocyte cell surface via hyaluronan/hyaluronan receptor interactions. Exogenous hyaluronan did not inhibit matrix assembly or displace intact matrices. High molecular weight hyaluronan added exogenously does bind to matrixfree chondrocytes McCarthy and Toole, 1989) , and thus may be incorporated into the matrix, exchanging for endogenous receptor-bound hyaiuronan and supporting proteoglycan aggregate formation and retention. However, in the presence of HA6, when potentially all cell surface hyaluronan receptors are occupied with hexasaccharides which are too small to mediate proteoglycan aggregate formation, the assembly and retention of the pericellular matrix is inhibited. Thus receptor-bound hyaluronan appears to serve as the periceUular matrix anchor.
When added to pre-chondrogenic micromass cultures established from embryonic chick limb bud mesoderm, HA~ inhibits chondrogenesis, a process believed to be mediated via hyaiuronan receptors (Toole, 1991; Maleski, M. P., and C. B. Knudson. 1992. Trans. Orthop. Res. Soc. 17:105) . A rnAb (IVd4) was generated by Toole and his colleagues (1991) , directed against a hyaluronan receptor present in embryonic chick tissues. Analogous to the HA~, this antibody blocks binding of 3H-hyaluronan to hyaluronan receptors (Banerjee and Toole, 1991) , inhibits assembly of newly synthesized pericellular matrices on chondrocytes (Yu et al., 1992) and inhibits chondrogenesis of micromass cultures (Toole, 1991) .
To determine the components minimally required to establish a chondrocyte pericellular matrix, namely a matrix that can exclude particles, purified exogenous macromolecules were added back to matrix-free chondrocytes. Only when exogenous hyaluronan was added in combination with intact aggrecan did a pericellular matrix assemble. The presence or absence of keratan sulfate on the aggrecan did not affect matrix assembly. These results suggest that the matrix observed by the particle exclusion assay depends on the space occupied by the chondroitin sulfate chains of the aggrecan. However, the aggrecan must interact with hyaluronan to be retained at the chondrocyte cell surface; the hyaiuronan being anchored to the cell surface via the hyaluronan receptor, and displaceable by HA6. The second conclusion of this study is that hyaluronan and intact aggrecan, decorating the hyaluronan in aggregate form, are essential for matrix formation. Addition of exogenous link-stabilized hyaluronan/ aggrecan aggregates also supported matrix assembly and, more importantly, the link-stabilized matrix could still be displaced by HA6. This also supports the conclusion that the displacement of the cell-associated, proteoglycan aggregate pericellular matrix by HA6 is via competition with hyaluronan/hyaluronan receptor interactions and not hyaluronan/ aggrecan interactions. This later interaction occurs between aggrecan and hyaluronan oligosaccharides of a decasaccharide size or larger, with specific structural requirements (Hascail and Heinegard, 1974; Christner et ai., 1977) .
To determine whether the addition of exogenously added macromolecules promoted matrix assembly by stimulation of endogenous matrix production, nonliving chondrocytes mildly fixed by treatment with 1% glutaraidehyde were assayed. Addition of hyaluronan and aggrecan to fixed chondrocytes in the absence of serum resulted in periceUular matrix assembly comparable to live chondrocytes. These matrices were stable for 24 h without continuous exposure to the soluble macromolecules. Therefore the third conclusion from our current results is that the formation of a pericellular matrix on chondrocytes can be obtained with as few as two components, the addition of exogenous hyaluronan and an aggregating type proteoglycan and that serum components are not required. No matrix formed if trypsin pre-treated cells were used demonstrating that matrix assembly is mediated via a cell surface-associated protein(s).
In previous studies, to substantiate the role of the hyaluronan receptor in matrix assembly exogenous hyaluronan and aggrecan were added to other cultured cell types (Knudson and Knudson, 1991) . The cell types chosen were ones which never exhibit pericellular matrices in culture, synthesize little hyaluronan or proteoglycan, yet do express hyaluronan receptors similar to those expressed on chondrocytes. Addition of hyaluronan plus aggrecan to two different human bladder carcinoma cell lines or to SV-40--transferred 3T3 cells, resulted in the assembly of chondrocyte-like pericellular matrices. As with the chondrocytes, hyaluronan, or aggrecan alone were unable to support matrix assembly; HA~ inhibited matrix assembly or displaced matrices once assembled; and glutaraldehyde-fixed tumor cells stiU supported matrix assembly. Addition of hyaluronan and aggrecan to matrix-deficient tumor cells which did not express hyaluronan receptors (B16 melanoma and RT-4 papilloma) were unable to assemble pericellular matrices. In addition, conditioned medium from rat fibrosarcoma cells (cells which exhibit pericellular matrices) also supported matrix assembly, suggesting that other hyaluronan-aggregating proteoglycans (e.g., versican, hyaiuronectin; see Toole, 1991) may also support matrix assembly.
The influence of hyaluronan on cell physiology probably depends on its hydrodynamic properties and its interaction with the cell surface (Laurent and Fraser, 1992) . Inhibition of chondrocyte proteoglycan biosynthesis in response to exogenous hyaluronan has been reported for several cell culture systems (Wiebkin and Muir, 1973; Solursh et ai., 1974 Solursh et ai., , 1980 Handley and Lowther, 1976; Bansal et al., 1986) although the results have reflected undetermined variability (reviewed in Mason et al., 1989) . In our studies, exogenous hyaiuronan did not inhibit matrix assembly or displace intact matrices. Also, total incorporation into 3~S-proteoglycans was not altered significantly in the presence of HA6. In the presence of HA~, there was an increased accumulation of newly synthesized proteoglycan in the medium compartment, which was competent to aggregate with hyaluronan. This suggests that a decrease in the synthesis of aggregating proteoglycans was not responsible for the blocked matrix assembly in the presence of HA6, but rather than the retention of aggrecan by receptor-bound hyaluronan in the pericellular matrix was blocked in the presence of HA6. These were 24-h experiments, and the long-term influence of matrix displacement via HAs on the chondrocyte phenotype is currently under study. Additionally, through the interaction of these matrix receptors with extracellular components, chondrocytes may fine tune their patterns of matrix biosynthesis and/or turnover, as has been previously suggested by several investigators (Wiebkin and Muir, 1973; Solursh et al., 1974 Solursh et al., , 1980 Handley and Lowther, 1976; Bansal et al., 1986; Morales and Hascail, 1988) .
Matrix assembly and retention at cell surfaces is important for the health of any tissue, cartilage in particular. Chondro-cyte interactions with extracellular matrices are important in the maintenance of tissue integrity, and for matrix assembly in repair and morphogenesis. These interactions are mediated via binding proteins/receptors for extracellular matrix molecules. Little is known about the distribution of integrins on chondrocytes. Anchorin CII is the major site to anchor chondrocytes in their collagen extracellular matrix (Mollenhauer et al., 1984) . In their studies, reassembly of the chondrocyte pericellular matrix was correlated with the intensity of anchorin CII immtmoreactivity on the cell surface (Mollenhauer et al., 1984) . Receptors with anchoring functions may also transduce information from the extracellular matrix influencing cell proliferation, differentiation, and physiology. The relationship between the interactions of the collagens and the proteoglycan aggregates with the chondrocyte surface is under investigation to further our understanding of the mechanisms used by chondrocytes to interact with the extracellular environment in healthy and diseased cartilage.
